It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(visit the link for the full news article)
New York : According to Dr T Ott the Swine Flu patent is owned by none other than Medimmune who stands to profit around $151 million dollars from US taxpayers.
Originally posted by novacs4me
I've been browsing through the patent, and it seems all related to H5N1, not to H1N1. Did I miss something?
Originally posted by new_guy_in_town
Originally posted by novacs4me
I've been browsing through the patent, and it seems all related to H5N1, not to H1N1. Did I miss something?
Medimmune holds a patent for reverse genetic recombination in regards to H1N1
[edit on 12-9-2009 by new_guy_in_town]
Originally posted by novacs4me
Originally posted by new_guy_in_town
Originally posted by novacs4me
I've been browsing through the patent, and it seems all related to H5N1, not to H1N1. Did I miss something?
Medimmune holds a patent for reverse genetic recombination in regards to H1N1
[edit on 12-9-2009 by new_guy_in_town]
Well, where is THAT patent, then? The document in the link in Time-to-Talk's post is an H5N1 related patent.
[0056]In further embodiments a vaccine or pharmaceutical composition is provided which comprises one or more viral antigens. Such a pharmaceutical composition can further comprise a pharmaceutical carrier and/or an adjuvant. Such pharmaceutical carriers are for example stabilising salts, emulgators, solubilisers or osmo-regulators, suspending agents, thickening agents, redox components maintaining a physiological redox potential. Pre-ferred adjuvants include aluminium salts, microemulsions, lipid particles, and/or oligonucleotides used to increase the immune response. A further aspect of the present invention is a pharmaceutical composition or preparation as vaccine comprising an antigen. A vaccine can be used e.g. for an injection as a prophylactic means against a virus associated disease. In particular preferred embodiments the composition or vaccine comprises more than one antigen, e.g. 2, 3, 4, 5, 6, 7 or 8, in particular of different virus strains, subtypes or types such as influenza A and influenza B, in particular selected from of one or more of the human H1N1, H2N2, H3N2, H5N1, H7N7, H1N2, H9N2, H7N2, H7N3, H10N7 subtypes, of the pig flu H1N1, H1N2, H3N1 and H3N2 subtypes, of the dog or horse flu H7N7, H3N8 subtypes or of the avian H5N1, H7N2, H1N7, H7N3, H13N6, H5N9, H11N6, H3N8, H9N2, H5N2, H4N8, H10N7, H2N2, H8N4, H14N5, H6N5, H12N5 subtypes.
FIG. 14: Shows modifications that can be engineered into the HA gene of A/Netherlands/219/03 HA to remove the polybasic cleavage site.
Originally posted by novacs4me
reply to post by new_guy_in_town
I had already done ALL of that, including having watched Jane's video on another thread. In fact, I read that paragraph on that page of the patent, which was small and irrelevant, twice, because it didn't seem to support the argument at all. Oh, well. I'll check back tomorrow. Maybe it will all make sense after a good night's sleep!